TEK and cancer: Therefore, the Ang-1/Tie-2 signalling pathway appears to be an ideal anti-cancer target, as its inactivation is expected to produce both direct (targeting prostate CSCs) and indirect (targeting tumour angiogenesis) anti-cancer effects.